Form 8-K - Current report:
SEC Accession No. 0001213900-25-022448
Filing Date
2025-03-11
Accepted
2025-03-11 08:00:27
Documents
14
Period of Report
2025-03-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0233841-8k_pmgc.htm   iXBRL 8-K 27768
2 FORM OF SHARE PURCHASE AGREEMENT ea023384101ex99-1_pmgc.htm EX-99.1 44310
  Complete submission text file 0001213900-25-022448.txt   259153

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE elab-20250307.xsd EX-101.SCH 3027
4 XBRL LABEL FILE elab-20250307_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE elab-20250307_pre.xml EX-101.PRE 22367
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0233841-8k_pmgc_htm.xml XML 3797
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25725891
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)